C1QBP,74-282aa, Human, E Coli from MYBIOSOURCE INC.

Search, find, compare suppliers for C1QBP,74-282aa, Human, E Coli products.

Edit 
Product NameC1QBP,74-282aa, Human, E Coli
DescriptionSequence: 74-282aa. Purity > 95% by SDS-PAGE. p32, HABP1, gC1qR, GC1QBP, SF2p32 NCBI Accession No: NP_001203 Description: Human complement component 1, q subcomponent binding protein (C1QBP) is a ubiquitously expressed multifunctional phospho-protein that interacts with the globular heads of C1q (gC1q). This protein also interacts with a wide range of ligands and is implicated in cell signaling. Recombinant C1QBP was expressed in E Coli and purified by conventional chromatography techniques. MW: 23.9kDa (210aa), confirmed by MALDI-TOF.
Size0.1 mg, 0.5 mg
Concentration1 mg/ml (determined by Bradford assay)
ApplicationsSDS-PAGE
Other Names[Complement component 1 q subcomponent binding protein; p33; HABP1; gC1qR; GC1QBP; SF2p32,Complement component 1 q subcomponent binding protein; C1QBP; Complement component 1; q subcomponent binding protein C1q globular domain binding protein; Complement component 1 Q subcomponent binding protein mitochondrial; GC1Q R; GC1q R protein; GC1QR; Glycoprotein gC1qBP; HABP 1; Hyaluronan binding protein 1; Mitochondrial matrix protein p32; p32; Pre mrna splicing factor SF2 P32 subunit precursor; Splicing factor SF2 associated protein.], [C1QBP; GC1QBP; HABP1; SF2P32; C1qBP]
Gene, Accession, CAS #[C1QBP], Gene ID: 708, NCBI: NP_001203, UniProt: Q07021
Catalog #MBS203217
Price$310, $720
Order / More InfoC1QBP,74-282aa, Human, E Coli from MYBIOSOURCE INC.
Product Specific ReferencesFogal V., et al (2008) Cancer Res. 68 (17):7210-8; Biswas AK., et al (2007) PLoS Pathog. 3 (9):1271-80.;
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Products

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.